WuXi Biologics (Cayman)

Compliant

Under AAOIFI Standard 21, WuXi Biologics (Cayman) is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.

Ticker2269

ExchangeHKEX

SectorBiologics Contract Development

Full ratios for WuXi Biologics (Cayman) (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding WuXi Biologics (Cayman) or any other security.